News & Events
Posted: December 30, 2014 at 3:44 am
NIH-funded study yields encouraging early results
Three-year outcomes from an ongoing clinical trial suggest that high-dose immunosuppressive therapy followed by transplantation of a person's own blood-forming stem cells may induce sustained remission in some people with relapsing-remitting multiple sclerosis (RRMS). RRMS is the most common form of MS, a progressive autoimmune disease in which the immune system attacks the brain and spinal cord. The trial is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and conducted by the NIAID-funded Immune Tolerance Network (ITN) .
Three years after the treatment, called high-dose immunosuppressive therapy and autologous hematopoietic cell transplant or HDIT/HCT, nearly 80 percent of trial participants had survived without experiencing an increase in disability, a relapse of MS symptoms or new brain lesions. Investigators observed few serious early complications or unexpected side effects, although many participants experienced expected side effects of high-dose immunosuppression, including infections and gastrointestinal problems. The three-year findings are published in the Dec. 29, 2014, online issue of JAMA Neurology.
These promising results support the need for future studies to further evaluate the benefits and risks of HDIT/HCT and directly compare this treatment strategy to current MS therapies, said NIAID Director Anthony S. Fauci, M.D. If the findings from this study are confirmed, HDIT/HCT may become a potential therapeutic option for people with this often-debilitating disease, particularly those who have not been helped by standard treatments.
Scientists estimate that MS affects more than 2.3 million people worldwide. Symptoms can vary widely and may include disturbances in speech, vision and movement. Most people with MS are diagnosed with RRMS, which is characterized by periods of relapse or flare up of symptoms followed by periods of recovery or remission. Over years, the disease can worsen and shift to a more progressive form.
In the study, researchers tested the effectiveness of HDIT/HCT in 25 volunteers with RRMS who had relapsed and experienced worsened neurological disability while taking standard medications. Doctors collected blood-forming stem cells from participants and then gave them high-dose chemotherapy to destroy their immune systems. The doctors returned the stem cells to the participants to rebuild and reset their immune systems.
Notably, participants did not receive any MS drugs after transplant, yet most remained in remission after three years, said Daniel Rotrosen, M.D., director of NIAIDs Division of Allergy, Immunology and Transplantation. In contrast, other studies have shown that the best alternative MS treatments induce much shorter remissions and require long-term use of immunosuppressive drugs that can cause serious side effects.
The study researchers plan to follow participants for a total of five years, recording all side effects associated with the treatment. Final results from this and similar studies promise to help inform the design of larger trials to further evaluate HDIT/HCT in people with MS.
The work was sponsored by NIAID, NIH, and conducted by the ITN (contract number N01 AI015416) and NIAID-funded statistical and clinical coordinating centers (contract numbers HHSN272200800029C and HHSN272200900057C). The ClinicalTrials.gov identifier for the study High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT-MS) is NCT00288626.
NIAID conducts and supports research at NIH, throughout the United States, and worldwide to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
See more here:
News & Events
- Most Common Multiple Sclerosis Treatments - March 21st, 2018
- Multiple Sclerosis Market in the US 2015-2019 - Research ... - August 1st, 2015
- Multiple Sclerosis: Treatment and Global Market - Research ... - July 1st, 2015
- Multiple Sclerosis Research: natalizumab has a ... - June 14th, 2015
- New Multiple Sclerosis Circulation Theory Links Posture ... - June 10th, 2015
- Stem cell research benefits Houston woman with multiple sclerosis - April 6th, 2015
- Stem cell research benefits area woman with multiple sclerosis - April 6th, 2015
- Is a loophole in stem cell law helping new therapy to thrive, or allowing dubious science? - April 4th, 2015
- Multiple sclerosis can be scary, but a new treatment holds promise - April 1st, 2015
- Hoping for a cure - February 11th, 2015
- Jan. 30: Sacrificing health, multiple sclerosis research, sunscreen in winter - February 2nd, 2015
- This Could Be Game-Changing News in the Battle Against Multiple Sclerosis - February 2nd, 2015
- Latest Sports SEE MORE - January 30th, 2015
- Ottawa Hospital leads Canadian clinial trial on stem cell therapy in MS patients - January 29th, 2015
- Early Study Says Stem Cells May Reverse Multiple Sclerosis Disability - January 22nd, 2015
- Jan. 21: Bisphenol A research, multiple sclerosis treatment - January 22nd, 2015
- Airdrian says costly treatment a scam - January 21st, 2015
- Saskatoon woman snared in alleged fraudulent MS trial held in India - January 20th, 2015
- The 'impossible' dream: City firm's MS claims not medically possible, says top researcher - January 18th, 2015
- Sask. MS patient recounts good experience with research firm now under question - January 16th, 2015
- City man who ran stem-cell trial for MS patients fabricated credentials, overstated results - January 15th, 2015
- Fallout from fake credentials - January 15th, 2015
- U of W cancels proposal for joint research study - January 15th, 2015
- City man who ran stem-cell trial for MS patients fabricated credentials, overstated treatment results - January 14th, 2015
- One MS patient's 'starting line' for stem cell therapy - October 14th, 2014
- First Spanish-Filipino biotech firm introduced - October 3rd, 2014
- Cambridge scientist Dr Su Metcalfe awarded 150k for ground-breaking MS trials - October 2nd, 2014
- New Mount Sinai Research Indicates Cells From Placentas are Safe for Patients with Multiple Sclerosis - September 29th, 2014
- Vaccine Against MS Being Developed at Baylor Institute for ... - September 25th, 2014
- Stem cells use 'first aid kits' to repair damage - September 18th, 2014
- MS stem-cell breakthrough led by Italians - September 9th, 2014
- Could Reprogrammed Cells Fight 'Untreatable' Diseases? - August 28th, 2014
- Ore. man gets results from stem cell transplant - July 29th, 2014
- Cell therapy for multiple sclerosis patients: Closer than ever? - July 28th, 2014
- Scientists 1 step closer to cell therapy for multiple ... - July 24th, 2014
- Monday, July 21, 2014 12:00 am - July 21st, 2014
- Stem cell researcher to use national prize to treat brain conditions - June 3rd, 2014
- Updates on Stem Cell Research and MS - Video - June 1st, 2014
- Stem cell therapy shows promise for multiple sclerosis - May 16th, 2014
- Mice with multiple sclerosis-like condition walk again after human stem cell treatment - May 16th, 2014
- Stem Cells Reverse MS-Like Illness in Mice - May 16th, 2014
- Stem Cell Therapy Shows Promise for MS in Mouse Model - May 16th, 2014
- Mice With MS-Like Condition Walk Again After Human Stem Cell Treatment - May 16th, 2014
- Tisch MS Research Center of New York Exceeds $300K Crowdfunding Target for FDA-Approved Stem Cell Trial - April 15th, 2014
- Whats Going Around: Multiple Sclerosis Research - April 8th, 2014
- Umbilical Cord Stem Cell Therapy Clinical Trial for Multiple Sclerosis Gets Green Light - April 3rd, 2014
- The Multiple Sclerosis Association of America Publishes 2014 MS Research Update - February 20th, 2014
- Deep TCR sequencing reveals extensive renewal of the T cell repertoire following autologous stem cell transplant in MS - February 19th, 2014
- Richard M. Cohen -- Stem cell cultivation - Video - January 28th, 2014
- MS patient to take part in pioneering experiment - January 20th, 2014
- Research in Multiple Sclerosis - January 14th, 2014
- Preferable treatment for MS found in allogenic bone marrow stem cells - December 19th, 2013
- Vitamin D may help fight MS: study - December 12th, 2013
- Multiple sclerosis research - Wikipedia, the free encyclopedia - November 7th, 2013
- Multiple Sclerosis: Hope Through Research: National Institute of ... - November 1st, 2013
- BrainStorm to Initiate Study for Multiple Sclerosis at Hadassah Medical Center - October 15th, 2013
- Bike 150 miles in two days to raise money for Multiple Sclerosis research - August 19th, 2013
- Stem cell spine injections for MS - trial approved - August 17th, 2013
- FDA Approves Stem Cell Clinical Trial For Multiple Sclerosis - August 15th, 2013
- Transatlantic partnership to tackle neurodegenerative disease - July 19th, 2013
- Multiple Sclerosis Drugs Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market ... - July 15th, 2013
- Revolution starts at bioscience campus - July 1st, 2013
- Advanced Sclerosis research at AIIMS soon - May 26th, 2013
- Stanford: treatment delays multiple sclerosis onset in mice - May 14th, 2013
- Turning Stem Cells Into Brain Cells To Cure Multiple Sclerosis And Cerebral Palsy - April 15th, 2013
- Major advance in understanding risky but effective multiple sclerosis treatment - March 27th, 2013
- New skin cell treatment offers new hope to MS patients - February 10th, 2013
- Cells forged from human skin show promise in treating MS, myelin disorders - February 7th, 2013
- Cells forged from human skin show promise in treating multiple sclerosis, myelin disorders - February 7th, 2013
- Birax grants NIS 25m for Israel-UK stem cell projects - January 22nd, 2013
- Multiple sclerosis drug may one day treat colorectal cancer - January 10th, 2013
- Stem Cell Showdown: Celltex vs. the FDA - January 4th, 2013
- ACADIA Pharmaceuticals to Receive Funding from Fast Forward and EMD Serono for Multiple Sclerosis Program - December 21st, 2012
- EMD Serono, Inc. and Fast Forward, LLC Announce Recipients of Funding for Multiple Sclerosis Research - December 21st, 2012
- Ballenger Trust Selects the Myelin Repair Foundation to Advance Myelin Repair Therapeutic Development for Multiple ... - December 18th, 2012
- Christchurch neurologist part of MS trial - December 17th, 2012
- Therafit Gym Multiple Sclerosis Jody MS (stem cell trial).wmv - Video - November 20th, 2012
- jodyMSvideo2012 0001 - Video - November 14th, 2012
- Stem Cell Transplants May Show Promise for Multiple Sclerosis - October 12th, 2012
- StemGenexâ„¢ on Adult Stem Cell-Based Therapy for Multiple Sclerosis - October 10th, 2012